glp-1 receptor agonist antipsychotic weight gain study Agonists in Mood Disorders: A Psychiatric Perspective GLP-1 Agonists For Obesity In
Description
J Diabetes Investig 14(6):767773
Results Patient population Thirteen T2D patients were enrolled and received at least one dose of SAR425899
Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: an update
( SIDEBAR 1 )
doi: 10.1038/nrneph.2010.58 65 SkovJDejgaardAFrokiaerJHolstJJJonassenTRittigSet al
